[HTML][HTML] The role of fibroblast growth factor 23 in inflammation and anemia
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - International Journal of Molecular Sciences, 2019 - search.proquest.com
Introduction Cardiovascular disease is the leading cause of mortality across all stages of
chronic kidney disease (CKD), and common occurrences such as fibroblast growth factor 23 …
chronic kidney disease (CKD), and common occurrences such as fibroblast growth factor 23 …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - 2019 - agris.fao.org
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - International Journal of Molecular Sciences, 2019 - cir.nii.ac.jp
抄録< jats: p> In patients with chronic kidney disease (CKD), adverse outcomes such as
systemic inflammation and anemia are contributing pathologies which increase the risks for …
systemic inflammation and anemia are contributing pathologies which increase the risks for …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
B Czaya, C Faul - International Journal of Molecular Sciences, 2019 - europepmc.org
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - International journal of molecular …, 2019 - pubmed.ncbi.nlm.nih.gov
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
[引用][C] The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - International Journal of Molecular Sciences (Web …, 2019 - jglobal.jst.go.jp
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia | Article Information | J-GLOBAL
Art J-GLOBAL ID:202102224772437811 Reference number:21A1306656 The Role of …
Art J-GLOBAL ID:202102224772437811 Reference number:21A1306656 The Role of …
[HTML][HTML] The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - International Journal of Molecular Sciences, 2019 - ncbi.nlm.nih.gov
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
B Czaya, C Faul - International Journal of Molecular …, 2019 - search.ebscohost.com
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
[PDF][PDF] The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
B Czaya, C Faul - Int. J. Mol. Sci, 2019 - pdfs.semanticscholar.org
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …